Elliott received his B.S. in biomedical engineering with a minor in entrepreneurship from The Ohio State University in 2014. His undergraduate research focused on the effect of intrastriatal injection of alpha-synuclein fibrils on ultrasonic vocalizations in rats under Dr. Shelia Fleming. Elliott is interested in the use of peripheral neuromodulation to treat diseases by utilizing the body’s own ability to respond chemically to neural stimuli. He is currently examining the efficacy of using targeted neurostimulation techniques to chronically control blood glucose.
Elliott Dirr
